{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:37:51Z","timestamp":1776285471496,"version":"3.50.1"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,10,3]]},"DOI":"10.18632\/oncotarget.19240","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T14:09:48Z","timestamp":1500041388000},"page":"78410-78418","source":"Crossref","is-referenced-by-count":15,"title":["Sites of extranodal involvement are prognostic in patients with stage 1 follicular lymphoma"],"prefix":"10.18632","volume":"8","author":[{"given":"Aditi","family":"Shastri","sequence":"first","affiliation":[{"name":"Division of Hematologic Malignancies, Department of Oncology, Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali","family":"Janakiram","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Department of Oncology, Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Mantzaris","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Department of Oncology, Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiting","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime S.","family":"Londono","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Department of Oncology, Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit K.","family":"Verma","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Department of Oncology, Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan K.","family":"Barta","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"key":"1","first-page":"3909","article-title":"The Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"89","author":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma","year":"1997","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin\u2019s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"16","author":"Weisenburger","year":"1998","journal-title":"J Clin Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Linet","year":"2006","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ajh.23674","article-title":"Follicular lymphoma: 2014 update on diagnosis and management","volume":"89","author":"Freedman","year":"2014","journal-title":"Am J Hematol"},{"key":"5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/annonc\/mds429","article-title":"Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices","volume":"24","author":"Shenoy","year":"2013","journal-title":"Ann Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Doyen","year":"2004","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Lister","year":"2014","journal-title":"J Clin Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/leu.2014.91","article-title":"How we manage follicular lymphoma","volume":"28","author":"Cheson","year":"2014","journal-title":"Leukemia"},{"key":"9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.6004\/jnccn.2011.0046","article-title":"Non-Hodgkin\u2019s lymphomas","volume":"9","author":"Harris","year":"2011","journal-title":"J Natl Compr Canc Netw"},{"key":"10","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1200\/JCO.2011.40.6546","article-title":"Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study","volume":"30","author":"Miller","year":"2012","journal-title":"J Clin Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1182\/blood-2007-01-067579","article-title":"p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma","volume":"110","author":"de Jong","year":"2007","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","article-title":"High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas","volume":"21","author":"Bartelink","year":"2003","journal-title":"J Clin Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ctrv.2014.05.010","article-title":"Primary breast lymphoma","volume":"40","author":"Seymour","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/annonc\/mdp238","article-title":"Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group","volume":"20","author":"Taghian","year":"2009","journal-title":"Ann Oncol"},{"key":"15","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Fierro","year":"2006","journal-title":"J Clin Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajh.23638","article-title":"Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database","volume":"89","author":"Olszewski","year":"2014","journal-title":"Am J Hematol"},{"key":"17","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/cncr.27898","article-title":"Using primary site as a predictor of survival in mantle cell lymphoma","volume":"119","author":"Flowers","year":"2013","journal-title":"Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1182\/asheducation-2016.1.269","article-title":"Prognostic factors in follicular lymphoma: new tools to personalize risk","volume":"2016","author":"Casulo","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/asheducation-2016.1.277","article-title":"Frontline strategy for follicular lymphoma: are we ready to abandon chemotherapy?","volume":"2016","author":"Fowler","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Tan, Horning, Hoppe, Levy, Rosenberg, Sigal, Warnke, Natkunam, Han, Yuen, Plevritis, Advani. Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood. 2013; 122:981\u2013987.","DOI":"10.1182\/blood-2013-03-491514"},{"key":"21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2013.07.019","article-title":"Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience","volume":"87","author":"Connors","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.23863","article-title":"Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management","volume":"90","author":"Wilcox","year":"2015","journal-title":"Am J Hematol"},{"key":"23","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Jaffe","year":"2011","journal-title":"Blood"},{"key":"24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1309\/AJCP4SUBR4NPSPTN","article-title":"Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions","volume":"143","author":"Beylot-Barry","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"25","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.2008.18.0513","article-title":"High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma","volume":"27","author":"Campo","year":"2009","journal-title":"J Clin Oncol"},{"key":"26","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.humpath.2012.03.025","article-title":"The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease","volume":"43","author":"Klapper","year":"2012","journal-title":"Hum Pathol"},{"key":"27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1158\/1078-0432.CCR-09-2487","article-title":"A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages","volume":"16","author":"Kimby","year":"2010","journal-title":"Clin Cancer Res"},{"key":"28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/annonc\/mdi076","article-title":"Central nervous system involvement in indolent lymphomas","volume":"16","author":"Paltiel","year":"2005","journal-title":"Ann Oncol"},{"key":"29","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0959-8049(00)00171-4","article-title":"Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis","volume":"36","author":"Holte","year":"2000","journal-title":"Eur J Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2141.2011.08596.x","article-title":"Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma","volume":"153","author":"Montserrat","year":"2011","journal-title":"Br J Haematol"},{"key":"31","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4143\/crt.2013.45.3.234","article-title":"A rare presentation of follicular lymphoma: cerebellar involvement, successfully treated with a combination of radiotherapy and chemotherapy","volume":"45","author":"Arpaci","year":"2013","journal-title":"Cancer Res Treat"},{"key":"32","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.7314\/APJCP.2012.13.10.4889","article-title":"Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis","volume":"13","author":"Sarangi","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"33","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3324\/haematol.2010.034264","article-title":"Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project","volume":"96","author":"Martos","year":"2011","journal-title":"Haematologica"},{"key":"34","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.7314\/APJCP.2014.15.14.5825","article-title":"Type distribution of lymphomas in Lebanon: five-year single institution experience","volume":"15","author":"Kattan","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"35","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network","volume":"105","author":"Roman","year":"2011","journal-title":"Br J Cancer"},{"key":"36","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ajh.21824","article-title":"Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification","volume":"85","author":"Huh","year":"2010","journal-title":"Am J Hematol"},{"key":"37","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1002\/cncr.27513","article-title":"Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study","volume":"118","author":"Flowers","year":"2012","journal-title":"Cancer"},{"key":"38","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/1055-9965.EPI-11-0038","article-title":"Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation","volume":"20","author":"Chang","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"39","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1002\/cncr.29491","article-title":"What is the optimal management of early-stage low-grade follicular lymphoma in the modern era?","volume":"121","author":"Beriwal","year":"2015","journal-title":"Cancer"},{"key":"40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial","volume":"100","author":"Hoskin","year":"2011","journal-title":"Radiother Oncol"},{"key":"41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/PPO.0b013e31826aed4f","article-title":"Has single-agent rituximab replaced watch-and-wait for a patient with asymptomatic low-grade follicular lymphoma?","volume":"18","author":"Ardeshna","year":"2012","journal-title":"Cancer J"},{"key":"42","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1470-2045(14)70027-0","article-title":"Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial","volume":"15","author":"Jack","year":"2014","journal-title":"Lancet Oncol"},{"key":"43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/jco.2003.05.128","article-title":"Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B.","volume":"21","author":"Gottlieb","year":"2003","journal-title":"J Clin Oncol"},{"key":"44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ajh.23708","article-title":"The impact of race, age, and sex in follicular lymphoma: a comprehensive SEER analysis across consecutive treatment eras","volume":"89","author":"Evens","year":"2014","journal-title":"Am J Hematol"},{"key":"45","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1158\/1055-9965.EPI-05-0549","article-title":"Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study","volume":"15","author":"Holly","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"46","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program. Research Data 1973-2009 (November 2011 Submission). National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Sys-tems Branch. Released April 2012. http:\/\/www.seer.cancer.gov\/."},{"key":"47","unstructured":"National Cancer Institute. Number of Persons by Race and Hispanic Ethnicity for SEER Participants (2000 Census Data)http:\/\/seer.cancer.gov\/registries\/data.html. Accessed September 2013."},{"key":"48","first-page":"101","article-title":"Disparities in receipt of radiotherapy and survival by age, sex, and ethnicity among patient with stage I follicular lymphoma","volume":"6","author":"Shah","year":"2016","journal-title":"Front Oncol"},{"key":"49","volume-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"Vardiman","year":"2008"},{"key":"50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/asheducation-2009.1.523","article-title":"The 2008 WHO classification of lymphomas: implications for clinical practice and translational research","volume":"2009","author":"Jaffe","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T13:02:43Z","timestamp":1589202163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":50,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2017,10,3]]}},"alternative-id":["19240","29108238"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.19240","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]}}}